Sanofi Logo

Epidemiology of Prostate Cancer

Epidemiology of Prostate Cancer

Prostate cancer is the most commonly occurring cancer among American men. Despite a relatively favorable prognosis, it is the second leading cause of cancer death in men1:

  • New US cases in 2009: 192,280
  • US deaths in 2009: 27,360

Incidence and Impact of Metastatic Disease in the US

  • About 5% to 7% of US patients present with metastatic disease2
  • Approximately 30,000 American men develop metastatic disease per year3

Risk Factors

While age, race, and family history are the established risk factors for prostate cancer, due to a heterogenous biology it has several prognostic factors1,4:

Prostate Cancer Risk Factors


1. American Cancer Society. Cancer Facts & Figures 2009. Atlanta: American Cancer Society; 2009. 2. Nation Cancer Institute. Prostate Cancer Screening (PDQ®). Accessed February 22, 2010. 3. Scher HI, Eisenberger M, D’Amico AV, et al. Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 2004;22(3):537-556. 4. Fitzpatrick JM, Sternberg CN, Saad F, et al. Treatment decisions for advanced genitourinary cancers: from symptoms to risk assessment. Eur Urol Suppl. 2009;8(9):738-746.

Sanofi joins the fight against prostate cancer

ON THE LINE is a prostate cancer awareness campaign and Sanofi is co-sponsoring this initiative to help educate men and women about the importance of prostate screening. The campaign focuses on health education that harnesses the power of sports and celebrities to challenge men to take charge of their health. ON THE LINE offers educational materials for both men and women on prostate cancer, to promote a true "team" approach.

And Sanofi is fighting prostate cancer every way we can too. We know the stakes. Prostate cancer is the most commonly diagnose cancer in American men today. Every five minutes two more men are diagnosed with the disease. And it's the second leading cause of cancer death in the U.S.

From our earliest days, the goals of our cancer research have remained steadfast: to battle cancer with the most effective agents we can develop, to reduce the side effects of chemotherapy and to create breakthrough therapies for cancer patients. With the availability of new research techniques, we are also investigating targeted agents and novel approaches that may one day play an important role in advancing cancer management.

For more information about ON THE LINE, visit

Share the fight against prostate cancer.
Visit ON THE LINE on Facebook and YouTube

[Top of Page]